Vivo Capital, LLC Homology Medicines, Inc. Transaction History

Vivo Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $671,474 - $1.51 Million	-483,075 Reduced 56.62%	370,068 $729,000
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $224,176 - $374,154	-22,553 Reduced 2.58%	853,143 $9.13 Million
Q2 2020 Aug 14, 2020	SELL	$12.07 - $19.34 $1.6 Million - $2.57 Million	-132,866 Reduced 13.17%	875,696 $13.3 Million
Q1 2020 May 15, 2020	BUY	$12.5 - $22.04 $12.6 Million - $22.2 Million	1,008,562 New	1,008,562 $15.7 Million
Q3 2019 Nov 13, 2019	SELL	$14.74 - $22.28 $17.1 Million - $25.8 Million	-1,159,742 Closed	0 $0

Q3 2018 Nov 13, 2018	SELL	$15.54 - $22.86 $3.89 Million - $5.72 Million	-250,000 Reduced 17.73%	1,159,742 $26.5 Million
Q2 2018 Aug 10, 2018	BUY	$16.49 - $21.55 $4.12 Million - $5.39 Million	250,000 Added 21.56%	1,409,742 $28.8 Million
Q1 2018 May 15, 2018	BUY	$18.66 - $18.7 $21.6 Million - $21.7 Million	1,159,742 New	1,159,742 $21.7 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.